Latest Capital Investment News

Capricorn Metals reported a strong June quarter with Karlawinda gold production meeting FY25 guidance and announced it is now debt free and unhedged. Development at Mt Gibson and Karlawinda Expansion projects progresses, supported by record cash flow.

Champion Iron Limited reported Q1 FY2026 results showing steady revenues and net income, alongside a major US$500 million bond issuance to refinance debt and a new partnership agreement for the Kami Project.

Immutep Limited advances its pivotal Phase III lung cancer trial and reports promising results across multiple oncology and autoimmune programs, supported by a solid cash position to fund operations through 2026.

Strike Energy reported a solid $18.8 million operating cash inflow for the June 2025 quarter, supported by $76.2 million in total available funding, positioning the company well for ongoing project development.

St Barbara Limited reports steady gold production and strong financials while progressing the Simberi Expansion Project, though a PNG tax dispute delays funding decisions.

Acrow Limited confirms FY25 financial guidance with solid sales and EBITDA growth, while securing a significant seven-year contract extension with Origin Energy that bolsters its Industrial Access division outlook for FY26.

Barton Gold Holdings reports robust progress in its June 2025 quarter, highlighting strong project economics, resource upgrades, and strategic acquisitions that position it for production by 2026.

Buru Energy advances its Rafael Gas Project in Western Australia with a focus on sustainable growth, targeting a final investment decision in 2026 and production start in 2028. The project aims to supply local power generation with trucked LNG and condensate, replacing costly imports.

PentaNet Ltd reported positive operating cash flow for the June 2025 quarter and strengthened its financial position with a new $2 million equipment finance facility.

Ora Banda Mining reported a 36% rise in FY25 gold sales and a strong cash position, despite some operational delays. The company’s FY26 guidance targets a 60% production increase, backed by significant exploration successes.

Epsilon Healthcare has emerged from voluntary administration with a stronger balance sheet, securing refinancing and preparing to launch its new pharmacy platform. Operational stability and strategic initiatives signal a turning point for the healthcare group.

Sandon Capital Investments announces a fully franked 1.4 cent dividend for the September quarter, reflecting robust FY2025 portfolio returns and a healthy dividend yield.